These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26251307)

  • 1. Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation.
    Banno F; Kita T; Fernández JA; Yanamoto H; Tashima Y; Kokame K; Griffin JH; Miyata T
    Blood; 2015 Nov; 126(19):2247-53. PubMed ID: 26251307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism.
    Maruyama K; Akiyama M; Kokame K; Sekiya A; Morishita E; Miyata T
    PLoS One; 2015; 10(7):e0133196. PubMed ID: 26186226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen Tochigi mice exhibit phenotypes similar to wild-type mice under experimental thrombotic conditions.
    Tashima Y; Banno F; Kita T; Matsuda Y; Yanamoto H; Miyata T
    PLoS One; 2017; 12(7):e0180981. PubMed ID: 28686706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Identification of Protein S K196E Mutation in a Patient With Cerebral Venous Thrombosis: A Case Report.
    Fujita K; Sonoda K; Miyata T; Ihara M; Toyoda K; Koga M
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):232-233. PubMed ID: 30352753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of protein S Tokushima-K196E with a risk of deep vein thrombosis.
    Ikejiri M; Wada H; Sakamoto Y; Ito N; Nishioka J; Nakatani K; Tsuji A; Yamada N; Nakamura M; Ito M; Nobori T
    Int J Hematol; 2010 Sep; 92(2):302-5. PubMed ID: 20811787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI.
    Maruyama K; Akiyama M; Miyata T; Kokame K
    Res Pract Thromb Haemost; 2018 Oct; 2(4):751-756. PubMed ID: 30349894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombophilia in East Asian countries: are there any genetic differences in these countries?
    Miyata T; Maruyama K; Banno F; Neki R
    Thromb J; 2016; 14(Suppl 1):25. PubMed ID: 27766051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers.
    Kimura R; Sakata T; Kokubo Y; Okamoto A; Okayama A; Tomoike H; Miyata T
    J Thromb Haemost; 2006 Sep; 4(9):2010-3. PubMed ID: 16961608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormality in blood coagulation because of protein S-K196E mutation].
    Miyata T; Okada H
    Brain Nerve; 2008 Nov; 60(11):1285-93. PubMed ID: 19069162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors.
    Giri TK; Yamazaki T; Sala N; Dahlbäck B; de Frutos PG
    Blood; 2000 Jul; 96(2):523-31. PubMed ID: 10887114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Cooley BC; Chen CY; Schmeling G
    Thromb Res; 2007; 119(6):747-51. PubMed ID: 16793123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
    Steen M; Norstrøm EA; Tholander AL; Bolton-Maggs PH; Mumford A; McVey JH; Tuddenham EG; Dahlbäck B
    Blood; 2004 May; 103(9):3381-7. PubMed ID: 14695241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
    Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S.
    Tsuda H; Urata M; Tsuda T; Wakiyama M; Iida H; Nakahara M; Kinoshita S; Hamasaki N
    Thromb Res; 2002 Feb; 105(3):233-9. PubMed ID: 11927129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein S K196E mutation, a genetic risk factor for venous thromboembolism, is limited to Japanese.
    Liu W; Yin T; Okuda H; Harada KH; Li Y; Xu B; Yang J; Wang H; Fan X; Koizumi A; Miyata T
    Thromb Res; 2013 Aug; 132(2):314-5. PubMed ID: 23721692
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive value of protein S-specific activity and ELISA testing in patients with the protein S K196E mutation.
    Miyoshi T; Maruyama K; Oku H; Asahara S; Hanada H; Neki R; Yoshimatsu J; Kokame K; Miyata T
    Thromb Res; 2020 Jan; 185():1-4. PubMed ID: 31731088
    [No Abstract]   [Full Text] [Related]  

  • 20. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.
    Koenen RR; Gomes L; Tans G; Rosing J; Hackeng TM
    Thromb Haemost; 2004 Jun; 91(6):1105-14. PubMed ID: 15175796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.